Literature DB >> 16106620

Peripheral neuropathies in human immunodeficiency virus infection.

Ahmet Höke1, David R Cornblath.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 16106620     DOI: 10.1016/s1567-424x(09)70358-7

Source DB:  PubMed          Journal:  Suppl Clin Neurophysiol        ISSN: 1567-424X


× No keyword cloud information.
  5 in total

1.  Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

Authors:  Ronald J Ellis; Debralee Rosario; David B Clifford; Justin C McArthur; David Simpson; Terry Alexander; Benjamin B Gelman; Florin Vaida; Ann Collier; Christina M Marra; Beau Ances; J Hampton Atkinson; Robert H Dworkin; Susan Morgello; Igor Grant
Journal:  Arch Neurol       Date:  2010-05

2.  Gene therapy with HSV encoding p55TNFR gene for HIV neuropathic pain: an evidence-based mini-review.

Authors:  Hirotsugu Kanda; Shue Liu; Megumi Kanao; Hyun Yi; Takafumi Iida; Wan Huang; Takayuki Kunisawa; David A Lubarsky; Shuanglin Hao
Journal:  Transl Perioper Pain Med       Date:  2017

Review 3.  Animal models of peripheral neuropathies.

Authors:  Ahmet Höke
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

4.  Phosphorylated CCAAT/Enhancer Binding Protein β Contributes to Rat HIV-Related Neuropathic Pain: In Vitro and In Vivo Studies.

Authors:  Hyun Yi; Shue Liu; Yuta Kashiwagi; Daigo Ikegami; Wan Huang; Hirotsugu Kanda; Takafumi Iida; Ching-Hang Liu; Keiya Takahashi; David A Lubarsky; Shuanglin Hao
Journal:  J Neurosci       Date:  2017-12-01       Impact factor: 6.167

5.  Comorbidity of restless legs syndrome and HIV infection.

Authors:  S Happe; L Kundmüller; D Reichelt; I-W Husstedt; S Evers
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.